v2.4.0.6
Financial Instruments (Details 1) (USD $)
In Thousands, unless otherwise specified
3 Months Ended
Mar. 31, 2013
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]  
Fair value of level 3 financial instruments as of December 31, 2012 $ 13,960
Assumed payments made by Pfizer or assignee (853)
Fair value adjustments 1,658
Fair value of level 3 financial instrument assets as of March 31, 2013 14,765
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]  
Fair value of level 3 financial instruments as of December 31, 2012 23,647
Assumed payments made by Pfizer or assignee (853)
Fair value adjustments 2,508
Fair value of level 3 financial instruments as of March 31, 2013 $ 25,302